publication date: Apr. 14, 2017

Permanent advisory board needed to combat scientific misconduct, NAS report recommends

By Paul Goldberg

Scientific organizations should establish an advisory board that would have the overarching mandate to foster research integrity across disciplines.

The recommendation is included in a report titled “Fostering Integrity in Research,” which was published by the National Academies of Sciences, Engineering, and Medicine earlier this week.

The proposed advisory body, which would be called the Research Integrity Advisory Board would “provide a continuing organizational focus for fostering research integrity that cuts across disciplines and sectors.”

The board would be established as an independent nonprofit organization. It would work with scientists, institutions, scientific societies, journals, regulators and research sponsors “to share expertise and approaches for addressing and minimizing research misconduct and detrimental research practices.”

“While various groups, institutions, and individuals are doing valuable work to foster and promote research integrity in the United States, no permanent organizational focus for efforts to foster research integrity at a national level currently exists,” the report states.

The advisory group would have no direct role in conducting investigations, serving instead as “a neutral resource based in the research enterprise that helps the enterprise respond to ongoing and future changes.”

The latest report accepts the definitions … Continue reading Permanent advisory board needed to combat scientific misconduct, NAS report recommends

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.